Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 363 record(s)

Req # A-2023-00006

All correspondence between public officials (Assistant Deputy Minister level or higher) and the City of Ottawa or Alstom, or internally between federal public officials, including between the Transportation Safety Board of Canada (TBS) employees and/or Transport Canada, related to TBS occurrences R22H0037 and R21H0099

Organization: Transportation Safety Board of Canada

42 page(s)
September 2023

Req # A-2023-00026

Please provide me with an electronic copy in the highest resolution possible the two Transportation Safety Board Engineering reports: LP 116/2002 - Exhaust Stack Analysis Temperature Determination LP 12/99C Exhaust Stack Analysis Temperature Determination

Organization: Transportation Safety Board of Canada

32 page(s)
September 2023

Req # A-2022-00052

I am seeking information regarding the following aircraft incident: at 1:46 p.m. on 15 November 2021, a privately registered Cessna R182 aircraft (registration C-FBKJ, serial number R18200149) departed on a visual flight rules (VFR) flight plan from Nanaimo Airport (CYCD), British Columbia (BC), to Glacier Park International Airport (KGPI), Montana, United States. The filed flight plan showed a direct route from CYCD to KGPI, flown at an altitude of 10 500 feet above sea level (ASL). A pilot and 1 passenger were on board. The aircraft crashed. A TSB investigation was conducted regarding the incident (Air transportation safety investigation report A21P0124). I am specifically looking for the following: a copy of the flight plan, a copy of the TSB Laboratory Report LP171/2021 including an electronic copy of all data used in the production of LP171/2021, Digital copies of all on-scene photographs taken by the TSB investigators, (copies of digital images, a copy of investigators notes, a copy of any radar data obtained for the investigation, a transcript of any conversations between the pilot and air traffic control, a copy of the aircraft Journey Logbook, a copy of the aircraft Technical Logbooks, a copy of any insurance certificate/proof of insurance, correspondence between Nav Canada and the TSB, correspondence between any insurance adjuster and/or Underwriter and the TSB

Organization: Transportation Safety Board of Canada

231 page(s)
August 2023

Nothing to report this month

Organization: Patented Medicine Prices Review Board Canada

August 2023

Req # A-2022-05111

Electronic copies of the following documents. In all cases, cabinet confidences may be excluded and draft versions of documents. In all of the requests below, “draft guidelines” refers to the PMPRB Guidelines that were published for comment on October 6, 2022, or any prior drafts or versions of those 2022 Guidelines (for example, if a draft version was circulated to Health Canada for comment in September 2022, it would be part of the “draft guidelines” for the purpose of this request). • Emails or other communications from Health Canada commenting on the draft guidelines, and that were sent between July 1, 2022, and October 6, 2022. • Emails or other communications from the Board members or Board Chair commenting on the draft guidelines, and that were sent between July 1, 2022, and October 6, 2022. • Any training presentations, training manuals, or summaries of the new guidelines prepared for use by the Board Staff, Board, or other governmental departments prepared between July 1, 2022, and October 6, 2022. • Any documents with calculations of how much prices will decrease under the draft guidelines, or under alternative pricing rules, and that were prepared between January 1, 2022, and October 6, 2022 (note the change in date relative to other requests). • Any documents comparing prices or price reductions under the draft guidelines and the old PMPRB Compendium of Guidelines and Procedures. • Any documents, including legal memos, on the compliance of the draft guidelines with legal decisions about the PMPRB, including Alexion Pharmaceuticals Inc. v. Canada (Attorney General), 2021 FCA 157, Merck Canada c Canada, 2022 QCCA 240, and Innovative Medicines Canada v. Canada (Attorney General), 2020 FC 725. • Any documents which discuss how a medicine’s therapeutic class and comparator products will be established under the draft guidelines. • Any documents showing how the Board Staff arrived at the exact pricing tests discussed in paragraph 33-35 of the draft Guidelines. • Any documents which discuss how Board Staff will assess whether a price is excessive *after* an investigation has been opened. For context, the backgrounder which accompanied the draft guidelines suggested that staff will consider “the totality of the circumstances surrounding the price of the medicine, through the lens of the section 85 factors.

Organization: Patented Medicine Prices Review Board Canada

197 page(s)
July 2023

Req # A-2023-025211

With regard to the c. 2003 HDAP Report on New Patented Drug - Angiomax (http://www.pmprbcepmb.gc.ca/view.asp?ccid=583), I am looking for a copy of any supporting research, reports and calculations used to determine dosage regimens. I am specifically interested in how these quantities (in mL) were derived, the benchmark patient weight that was used (in kg) and the timeframe of the dosing.

Organization: Patented Medicine Prices Review Board Canada

18 page(s)
July 2023

Req # A-2023-025599

For FY 2015-2022 (inclusive), how many investigations into prescription pricing on the basis that the pricing exceeded the guidelines resulted in a public hearing? Of those that resulted in a public hearing, in how many was the pricing found to be excessive? Of those that were found to be excessive, how many resulted in orders to reduce the prescription price?

Organization: Patented Medicine Prices Review Board Canada

1 page(s)
July 2023

Req # A-2023-025896

For fiscal years 2015-2022 (inclusive), how many new patented medicines were reported to the board by Bayer, Inc.? From among those reports, how many included claims that a price exceeded the guidelines?

Organization: Patented Medicine Prices Review Board Canada

588 page(s)
July 2023

Req # A-2023-025600

For FY 2015-2022 (inclusive), how many Advance Certificate Rulings were issued by the board?

Organization: Patented Medicine Prices Review Board Canada

0 page(s)
July 2023

Req # A-2023-00018

Digital copy of TSB report TP 6254E ‘Light Bulb Filament Impact Dynamics Study’ and TP 6255E ‘A guide to Light Bulb Analysis

Organization: Transportation Safety Board of Canada

221 page(s)
July 2023
Date modified: